GlyCemic Control with Add-On Medication Use for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy

被引：0
|
作者：
Fu, Alex Z.
Qiu, Ying
Radican, Larry
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A612 / A613
页数：2
相关论文
共 50 条
  • [21] Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)
    Kadowaki, Takashi
    Haneda, Masakazu
    Inagaki, Nobuya
    Taniguchi, Atsushi
    Sakamoto, Masashi
    Koiwai, Kazuki
    Rattunde, Henning
    Woerle, Hans J.
    Broedl, Uli C.
    [J]. DIABETES, 2013, 62 : A297 - A298
  • [22] Saxagliptin vs Glipizide as Add-On Therapy to Metformin for Type 2 Diabetes Mellitus (T2DM): Long-Term Safety and Efficacy
    Goeke, Burkhard
    Gallwitz, Baptist
    Eriksson, Johan
    Bokelund-Singh, Sara
    Gause-Nilsson, Ingrid
    [J]. DIABETES, 2011, 60 : A305 - A305
  • [23] Inappropriate metformin prescribing in elderly type 2 diabetes mellitus (T2DM) patients
    Kosmalski, M.
    Drozdowska, A.
    Sliwinska, A.
    Drzewoski, J.
    [J]. ADVANCES IN MEDICAL SCIENCES, 2012, 57 (01): : 65 - 70
  • [24] Add-On Treatment with Liraglutide Improves Glycemic Control in Patients with Type 2 Diabetes on Metformin Therapy
    Chiefari, Eusebio
    Capula, Carmelo
    Vero, Ada
    Oliverio, Rosa
    Puccio, Luigi
    Liguori, Rossella
    Pullano, Vittorio
    Greco, Manfredi
    Foti, Daniela
    Tirinato, Domenico
    Vero, Raffaella
    Brunetti, Antonio
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 (07) : 468 - 474
  • [25] DELAYED TREATMENT MODIFICATIONS FOR PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) WITH VERY POOR GLYCEMIC CONTROL
    Schwab, P.
    Saundankar, V
    Bouchard, J. R.
    Moretz, C.
    Baltz, J.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A264 - A264
  • [26] Adherence to Treatment Guidelines in Type 2 Diabetes (T2DM) Patients Treated with Metformin (MET) Monotherapy with Suboptimal Glycemic Control in Israeli Managed Care
    Goldshtein, Inbal
    Tunceli, Kaan
    Radican, Larry
    Katzeff, Harvey
    Yu, Shengsheng
    Voss, Bernd
    Sharon, Ofer
    Gadir, Noga
    Brodovicz, Kimberly
    Shalev, Varda
    Chodik, Gabriel
    Karasik, Avraham
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 111 - 111
  • [27] Adherence to Treatment Guidelines in Type 2 Diabetes (T2DM) Patients Treated with Metformin (MET) Monotherapy with Suboptimal Glycemic Control in Israeli Managed Care
    Tunceli, Kaan
    Goldstein, Inbal
    Radican, Larry
    Katzeff, Harvey
    Yu, Shengsheng
    Voss, Bernd
    Sharon, Ofer
    Gadir, Noga
    Brodovicz, Kimberly
    Shalev, Varda
    Chodik, Gabriel
    Karasik, Avraham
    [J]. DIABETES, 2014, 63 : A304 - A304
  • [28] COST-EFFECTIVENESS OF CANAGLIFLOZIN (CANA) VERSUS SITAGLIPTIN (SITA) AS ADD-ON TO METFORMIN PLUS SULFONYLUREA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) IN BRAZIL
    Pititto, L.
    Neslusan, C.
    Teschemaker, A. R.
    Johansen, P.
    Willis, M.
    Asano, E.
    Puig, A.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A864 - A864
  • [29] THE COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS INSULIN-SECRETAGOGUES (SULPHONYLUREAS) OR INSULIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) AS AN ADD-ON TO METFORMIN IN IRELAND
    Bacon, T.
    Willis, M.
    Johansen, P.
    Neslusan, C.
    Nuhoho, S.
    Worbes-Cerezo, M.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A346 - A346
  • [30] Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)
    Ford, Daniel M.
    Baz-Hecht, Merav
    Said, Nabil A.
    Tao, Ben
    Truitt, Kenneth E.
    Chou, Hubert S.
    [J]. DIABETES, 2013, 62 : A273 - A273
12345